SB 200646 HYDROCHLORIDE |
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐 |
143797-62-0 |
3-AP |
[(3-氨基吡啶-2-基)亚甲基氨基]硫脲 |
143621-35-6 |
Y27632 (hydrochloride) |
Y27632 (HYDROCHLORIDE) |
129830-38-2 |
CP21R7(CP21) |
GSK-3Β抑制剂(CP21R7) |
125314-13-8 |
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)- |
3-去氮腺嘌呤A |
120964-45-6 |
(Z)-1-(2-Chloro-2-(2,4-dichlorophenyl)ethenyl)-(1H)-1,2,4-triazolehydrochloride |
氯瑞唑 |
117857-45-1 |
Cabozantinib |
卡博替尼 |
849217-68-1 |
3-[4-Hydroxy-3-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(pentyloxy)-2-naphthalenyl]phenyl]-2-propenoicacid |
UVI 3003 |
847239-17-2 |
SU 5416 |
SU5416 |
204005-46-9 |
AMMONIUM TRICHLORO[1,2-ETHANEDIOLATO-O,O']-TELLURATE |
AS101 |
106566-58-9 |
UNC-0642 |
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 |
1481677-78-4 |